WIXOM, Mich., Nov. 8, 2007 (PRIME NEWSWIRE) -- Rockwell Medical Technologies, Inc. (NasdaqGM:RMTI - News), a leading, innovative manufacturer and developer of renal drug therapies and essential dialysate products, reported record quarterly sales of $11.1 million for the third quarter of 2007, up 50% over the third quarter of 2006. Sales for the first nine months of 2007 increased 60% compared to the first nine months of 2006. Third quarter loss per share was ($.04) compared to ($.14) in the third quarter last year. Rockwell’s third quarter loss of ($432,912) included research and development expense of $735,393 for its physiological iron maintenance therapy drug (SFP).
